文章核心观点 - 介绍投资组合表现及推荐BILL Holdings股票 [1][2] 分组1：投资组合情况 - 《内部人士论坛》模型投资组合自推出以来回报率超罗素2000指数两倍 [1] - 《内部人士论坛》投资组合由Bret Jensen管理，包含12 - 25只不同行业的股票，目标是长期跑赢罗素2000指数 [2] 分组2：股票情况 - 首次关注BILL Holdings公司股票，该SaaS公司股票近期飙升，股价可能形成双顶 [2]

Shares of Toyota Motor (TM 4.61%) rallied 4.8% on Wednesday as of 2:23 p.m. ET.Toyota is the largest automaker in the world, so its stock hasn't escaped the slowdown in auto sales that came after the height of the pandemic. However, as today's results showed, it's navigating the difficult auto market far better than rivals.Toyota beats and announces EV investmentsUnlike some of its electric vehicle (EV) and legacy auto rivals reporting this earnings season, Toyota's results were stronger than expected. Reve ...

It's been a rocky few months for Novo Nordisk.Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground to rival Zepbound from Eli Lilly. Wegovy's potential successor, CagriSema, came up short of investor expectations in a closely watched Phase 3 trial. Novo's stock has fallen more than 20% over the last year, and people feared things would get even worse when the company released fourth-quarter earnings and its 2025 outlook on Wednesday.Instead, Novo beat fourth-quarter expectations ...

文章核心观点 文章围绕High Tide公司展开，介绍其业务模式、进军德国市场的情况及战略规划，强调公司在行业中的优势和发展潜力，认为德国市场将助力公司提升业绩，未来有望拓展至更多国际市场 [2][5][64] 公司业务模式 - 公司通过Canna Cabana品牌成为加拿大最大的大麻零售商，在加拿大5个省份拥有191家运营门店 [2] - 在美国拥有三个顶级消费配件平台（仅在线），以及三个顶级国际CBD品牌（两个在美国，一个在英国），均属于Cabana Club [3] - 采用折扣俱乐部模式，在实体店和线上均保证大量大麻及相关产品的最低价格，自12月2日网络星期一推出国际Cabana Club后，在消费配件和CBD平台也采用相同模式 [4] 进军德国市场 市场机遇 - 德国自2024年4月大麻合法化后，市场需求激增，从2024年Q3或Q4的20吨销量来看，较上一年的8吨增长了250%，且超50%的医用大麻采购自加拿大，若加上葡萄牙对加拿大产品的转化，加拿大供应占比接近65% - 70% [13][14] - 德国政府考虑通过科学试点项目允许公司开设类似瑞士的商店，公司团队已为此准备两年，并与德国知名学术机构合作开展试点项目 [10][11] Purecan收购 - 公司通过多数股权收购Purecan进入德国医用大麻市场，Purecan是一家盈利的药品批发商和进口商，年化收入运行率为1500万欧元，毛利率约40%，EBITDA利润率为29% [5][20] - 公司以480万欧元收购51%股权，其中240万欧元以High Tide股票支付，120万欧元以现金支付，120万欧元作为本票在2年内支付，年利率7%且无提前还款罚款，18个月后可按相同3倍倍数收购剩余49%股权 [24] 竞争优势 - 公司凭借在加拿大6年累计15亿美元的大麻销售额和每年5亿美元的实体店大麻销售运行率，与加拿大所有持牌生产商建立了良好关系，能够获得他们10% - 15%的产量，并被提供加拿大一些大品牌的直接分销权 [16][18][19] - 公司计划打造一个包含200多种菌株的医用大麻菜单，展示加拿大最好的大麻品牌 [19] 风险与挑战 - 最大风险是若采购非GMP制造商的产品，从GACP转化为EUGMP需要4 - 8个月时间，且产品测试需符合双方标准 [27][28] - 前期准备工作可能需要4 - 12周，包括将感兴趣的菌株在加拿大持牌生产商的种植许可证上注册 [30] 公司竞争关系 - 公司认为Tilray是其互补伙伴，而非竞争对手，因为公司不种植大麻，专注于下游市场，与Tilray等种植商不存在业务竞争，且双方有意在海外拓展合作 [33][34][36] - 公司在德国市场没有销售基础，不存在自我竞争，且与生产伙伴的利润模式不同，未来将推出自有品牌产品，也会交给合作伙伴生产 [38][39] 美国市场策略 - 公司热爱美国市场，但目前不急于进入，认为美国市场需要联邦层面的合法化机会，且公司在加拿大和欧洲市场有足够的发展空间 [43][44][47] - 公司认为其折扣俱乐部模式在美国市场有很大潜力，即使在饱和市场也能发挥作用 [45] 公司财务与估值 - 公司收入从2018或2019年的800万美元增长到如今的超5亿美元，连续10 - 13个季度超过分析师共识预期，拥有6 - 7位分析师的覆盖 [50][51][52] - 上一季度（Q4）自由现金流为590万美元，过去四个季度累计自由现金流为2200万美元，分析师的轻微修订主要是由于公司的战略指导，如德国市场开发和全球Cabana Club的推出会有前期费用 [53][54] 公司未来规划 - 未来2 - 3年，公司计划实现300家门店的目标，在安大略省新增75家门店，在加拿大其他地区新增110 - 120家门店，有望使全国市场份额超过15% [62][63] - 公司将在欧洲市场，特别是德国市场，实现更高的毛利率和更好的业绩，为进入美国市场做好准备 [63][64]

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased ESSA Pharma Inc. securities during the Class ...

Eli Lilly And Co LLY will be reporting its fourth-quarter earnings on Thursday. Wall Street expects $4.94 in EPS and $13.66 billion in revenues as the company reports before market hours.The stock is up 19.23% over the past year, 8.22% YTD.Let’s look at what the charts indicate for Eli Lilly stock and how the stock currently maps against Wall Street estimates.Read Also: Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight LossLLY Stock Strongly Bullish Ahead Of Q4 Earnings LLY ...

Amgen Inc. (NASDAQ: AMGN ) reported strong earnings on Tuesday after the bell, outperforming analyst's expectations for earnings and revenue in Q4. In addition, the company initiated 2025 guidance that was generally in-line with analyst's expectations. The market was pleased by Amgen'sBrendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Therav ...

Trading in Netflix, Inc. NFLX is quiet Wednesday as the stock continues to consolidate. But there is a chance the recent uptrend may be about to resume.The price action in the stock may be creating a classic ‘Flag Pattern'. It has bullish implications and suggests that the shares may move higher. This is why it is our Stock of the Day.Technical analysts look for patterns on charts. These patterns form as a result of the price action of a stock.For example, if the leadership of a market changes from bears to ...

Banco Santander credited its technology platforms with helping it achieve record results in 2024.“As one of the largest retail and consumer banks in the world, we have the scale to build our own technology platforms, making it possible to offer customers the best products and services while constantly reducing the cost-to-serve,” Banco Santander Executive Chair Ana Botín said in a Wednesday (Feb. 5) earnings release. “This is a key competitive advantage and is reflected in our results through continuous imp ...

文章核心观点 - 游戏公司Roblox股价上涨，在财报公布前表现良好，期权交易活跃，过往财报后表现偏积极，此次期权市场预计股价波动较大 [1][2][4] 股价表现 - Roblox股价上涨1.3%，至74.75美元，处于三年高位，同比涨幅达85.4% [1] - Wedbush将其目标价从67.50美元上调至83美元 [1] 期权交易情况 - 期权交易活跃，已成交62000份看涨期权和38000份看跌期权，是日均期权交易量的3倍，2/7行权价83的看涨期权最受欢迎且有新头寸开仓 [2] - 在ISE、CBOE和PHLX，RBLX 50日看涨/看跌期权成交量比率为3.41，高于过去一年98%的读数 [3] 财报后表现 - 过去八次财报公布后次日股价走势中，有五次上涨 [4] - 此次期权市场预计股价无论涨跌将有18.6%的大幅波动，高于过去两年平均15.8%的波动幅度 [4]